| INTRODUCTION
Cartilage defect is frequently caused by inflammation, trauma, tumour, etc. The damaged cartilage cannot be fully regenerated due to its poor intrinsic healing capacity to reconstitute the integrated matrix and regenerate native surface. Till now, many approaches, ranging from symptomatic treatment to structural cartilage regeneration, have obtained limited results. Recently, stem-cell-induced tissue regeneration has emerged as a promising strategy for cartilage regeneration or repair.
Mesenchymal stem cells (MSCs) are a reliable resource for tissue regeneration. They are multipotent cells which are capable to differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes and adipocytes, etc. Recently, a new population of MSCs has been isolated from dental and craniofacial tissues, including but not limited to periodontal ligament stem cells (PDLSCs), dental pulp stem cells and stem cells from apical papilla. Numerous studies demonstrated that dental stem cells are derived from neural crest cells.
Superior proliferation capacity and multipotent differentiation potential were shown in dental stem cells compared with bone marrow MSC. 1 Previous study showed that PDLSCs exhibited greater osteo/ dentinogenic differentiation potentials compared with Wharton's jelly of umbilical cord stem cells. 2, 3 Meanwhile, PDLSCs are convenient to obtain and free of any ethical controversy. Therefore, this population of MSCs might be good resource for cartilage regeneration. However, the molecular mechanisms underlying chondrogenic differentiation of PDLSCs remain unclear, which restrict the potential application of PDLSCs in this field.
The mechanism of MSC differentiation is complicated both in temporal and spatial dimensions, in which covalent histone modifications are thought to play a critical role and be of essential importance in regulating chromatin dynamics and functions. 4, 5 Among them, histone methylation occurs on both lysine and arginine residues, participating in diverse biological processes including cell proliferation, differentiation, development, etc. Histone lysine methylation is controlled by histone lysine methyltransferases (KMTs) and histone lysine demethylases (KDMs). Histone H3 lysine 27 (H3K27) methylation has been mainly linked to transcription repression 6 and can be removed by KDM, including KDM6A and KDM6B. H3K27me3 demethylases likely play an important role in driving embryonic stem cell (ESC) differentiation. Lysine-specific demethylase6A (KDM6A), located on Xp11.3 and also referred as UTX, is one of histone H3K27 specific demethylase.
It has been demonstrated to be critical in the regulation of stem cells, including M2 macrophage differentiation, muscle differentiation and neuronal stem cell differentiation. 7 Functional studies showed that KDM6A overexpression in MSCs promotes osteogenesis and inhibits adipogenesis, while knockdown of KDM6A inhibits osteogenesis and promotes adipogenesis. 8 These findings indicate a positive role of KDM6A in osteogenesis but a negative role in adipogenic differentiation of MSCs. However, the function of KDM6A in chondrogenesis is still poorly understood.
Herein, we hypothesized that KDM6A may play a role in chon- 
| MATERIALS AND METHODS

| Cell cultures
| Virus infection
Virus for shRNA was a kind of gift from Dr. Fan, Capital Medical University School of Stomatology, China. Viral infection was conducted as previously described 3 , and PDLSCs were plated overnight and then infected with lentiviruses in the presence of polybrene (6 μg/mL; Sigma-Aldrich) for 6 hours. Cells were then selected with puromycin for 48 hours. Resistant clones were pooled, and knockdown was confirmed via real-time RT-PCR. The target sequences for KDM6A shRNA (KDM6Ash) were 5′-TTTATTCCTTAGTCTATGTGC-3′.
| Cell viability assay
Wild-type PDLSCs (PDLSCs-WT) and PDLSCs-KDM6Ash were seeded into 96-well plate (5000/well). Then, the cell counting kit-8
(CCK-8) (Dojindo, Kamimashiki-gun, Kumamoto, Japan) was used to determine cell viability after 1-to 8-day incubation or 3-day chondrogenic/osteogenic culture. The optical densities (OD) were measured at 450 nm. These experiments were performed 3 times. 
| Cell apoptosis assay
| Micromass culture
The micromass culture was based on the methods of Zhu et al. 10 The micromass was formed by resuspending 2 × 10 6 cells in 200 μL of growth medium. The cell suspension was gently pipetted into the middle of a single well of a 6-cm dish and was left overnight at 37°C, 5% CO 2 , before adding an additional 1 mL of chondrogenic medium.
The medium was changed every 2-3 days for 21 days. Micromasses were rinsed, dehydrated, stained with 1% Alcian blue solution for 30 min, rinsed with PBS for 3 times and fixed on slides.
| Alcian blue stain analysis
Blue staining indicated synthesis of proteoglycans by chondrocytes.
To quantify proteoglycans synthesis, Alcian blue was extracted by 4m guanidine-HCl overnight at 4°C. Absorbance values were read at 600 nm after temperature equilibration. The final OD value in each group was normalized with the total protein concentrations prepared from a duplicate plate.
| Sirius Red stain
Sirius Red staining was conducted as previously described. 11 Briefly, the micromasses were dehydrated, sealed by neutral balsam, stained with 1 g/L picric acid-Sirius Red at 37°C for 1 hour, and then washed with water. The micromasses were mounted and viewed under a microscope and captured images.
| Real-time PCR analysis
Total RNA was isolated from PDLSCs with Trizol reagents (Life Technologies). We synthesized cDNA from 2 mg aliquots of RNA, random Hexamers or oligo (dT), and reverse transcriptase, according to the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA).
Real-time RT-PCR reactions were performed with the QuantiTect SYBR Green PCR kit (Qiagen, Duesseldorf, Germany) and an Icycler iQ Multi-colour Real-time PCR detection system. To detect the expression of miRNAs, real-time PCR was performed using miDETECT A Track™ miRNA qRT-PCR Starter Kit (RIBOBIO, Guangzhou, China).
U6 RNA was used as an internal control for miRNA detection. Table S1 presents the primers for specific genes.
| Western blot analysis
Cells were lysed in RIPA buffer ( 
| Immunofluorescence
The monolayer cultured cells were rinsed with PBS buffer, fixed and 
| Chromatin immunoprecipitation assays
Briefly, cells were incubated with 1% formaldehyde for 10 minutes at 37°C. Each chromatin immunoprecipitation (ChIP) reaction was performed using 2 × 10 6 cells. For DNA precipitation, we added 2 mg polyclonal antibodies against trimethyl H3K4 
| RESULTS
| Depletion of KDM6A had no effect on cell viability and apoptosis of PDLSCs
In order to identify the characteristics of the isolated cells, fluorescenceactivated cell sorter analysis was performed and demonstrated that human PDLSCs display specific MSC markers such as CD90, STRO-1, SSEA-4 and OCT-4, while not expressing hematopoietic lineage markers such as CD 45 (Fig. S1C) . To investigate the differentiation potential of PDLSCs, cells were induced in osteogenic medium, chondrogenic medium and adipogenic medium, and we found that PDLSCs have the potential of multilineage differentiation ( Fig. S1D-F) . These data confirmed the MSC properties of PDLSCs.
After virus infection and antibiotics selection, the knockdown efficiency in PDLSCs-KDM6Ash was around 94.95% compared with PDLSCs-WT, which was verified by real-time RT-PCR ( Figure 1A ).
Next, we compared the proliferative activity of PDLSCs-WT with PDLSC-KDM6Ash by CCK8 assay. We found that during 8 days of culture, the cell viability of PDLSCs-WT and PDLSCs-KDM6Ash showed no significant difference ( Figure 1B) . Then, cells were induced with chondrogenic and osteogenic medium, the cell viability showed no significant difference ( Figure 1C) . To test the apoptosis of PDLSCs, flow cytometric assay was performed by measuring the percentage of Annexin V positive cells. As observed, there was no significant difference of apoptotic cells percentage between PDLSCs-WT and PDLSCsKDM6Ash (P > .05, Figure 1D ).
| Depletion of KDM6A repressed chondrogenic differentiation potential of PDLSCs
To assess whether depletion of KDM6A affects the chondro- PDLSCs-KDM6Ash compared with PDLSCs-WT at time points of 1, 2 and 3 weeks after chondrogenic induction. The expression of ACAN was decreased in PDLSCs-KDM6Ash compared with PDLSCs-WT at time points of 2 and 3 weeks (P < .05, Figure 2D ).
| Depletion of KDM6A resulted in increased H3K27me3 and decreased H3K4me3 in PDLSCs
To investigate the mechanism of KDM6A promoting chondrogenic differentiation potential of PDLSCs, we examined the H3K27me3 
KDM6Ash compared with PDLSCs-WT (Figure 3C-E). The level of H3K27me3 remains higher and H3K4me3 remains lower in the
PDLSCs-KDM6Ash after 3 days of chondrogenic induction (Fig. S2 ).
| Depletion of KDM6A resulted in increased H3K27me3 and decreased H3K4me3 in SOX9 promoter
Aim to prove that KDM6A promotes chondrogenic differentiation of
PDLSCs by demethylation of SOX9, we next performed a ChIP assay.
The results indicated that KDM6A silencing increased the H3K27me3 level in the SOX9 promoter ( Figure 3F ), suggesting that KDM6A
promoted SOX9 transcription by decreasing H3K27 trimethylation.
Interestingly, we also found that depletion of KDM6A in PDLSCs resulted in decreased level of H3K4me3 in the SOX9 promoter.
| EZH2 inhibitor rescued the chondrogenic potential of PDLSCs by decreased H3K27me3 after depletion of KDM6A
EPZ-6438 is a potent, selective and orally bioavailable small-molecule inhibitor of H3K27me3 methyltransferases (EZH2), and it could inhibit the activity of human PRC2-containing wild-type EZH2. Herein, we hypothesis that EPZ-6438 could rescue the repression of chondrogenic differentiation potential of PDLSCs after knockdown of
KDM6A. Thus, we treated PDLSCs with series EPZ-6438 solution,
of which concentration ranged from 0 mM to 1.5 mM. During 8 days of culture, PDLSCs-WT with 0.5 mM and 1.0 mM EPZ-6438 showed similar proliferation activity with PDLSCs-WT. However, cell proliferation activity of PDLSCs was significantly lower when treated with 1.5 mM EPZ-6438 (Fig. S3) . Therefore, 1.0 mM solution of EPZ-6438 was employed in the following procedures.
Next, we investigated the effect of EPZ-6438 on chondrogenic differentiation potential of PDLSCs-WT and PDLSCs-KDM6Ash.
After induction with chondrogenic medium for 2 weeks, the Alcian blue staining and Sirius Red staining for monolayer cultures and micromasses results revealed that proteoglycans and collagen production in PDLSCs-KDM6Ash was significantly increased when treated with EPZ-6438; however, EPZ-6438 has shown no effect on chondrogenic differentiation of PDLSCs-WT (P < .01, Figure 4A ,B). Together, these results support the hypothesis that EZH2 inhibitor could rescue impaired chondrogenic potential of KDM6A-depleted
PDLSCs by decreasing H3K27me3.
| miRNAs were involved in chondrogenesis of PDLSCs
Runx2 is the target gene of miR-204 and miR-211 and is the key transcription factor regulating osteogenesis and chondrogenesis. Realtime RT-PCR showed that the mRNA level of Runx2 was increased in PDLSCs at time point of 3 d of chondrogenic induction, and was decreased after 1, 2 and 3 weeks of induction (P < .05, Figure 6A ).
During 3 weeks of chondrogenic differentiation, real-time PCR
showed that the levels of miR-204 and miR-211 were decreased after knockdown of KDM6A, while inducing PDLSCs-KDM6Ash with EPZ-6438, the expressions of miR-204 and miR-211 were rescued, without significant difference with PDLSCs-WT at the time point of 3 weeks (P < .05, Figure 6C ,D). And it was also revealed that while inducing
PDLSCs with chondrogenic medium for 3 weeks, the expression of miR-29a was decreased. After knockdown of KDM6A, the expression of miR-29a was increased, while inducing PDLSCs-KDM6Ash
with EPZ-6438, the expression of miR-29a was decreased, showed no significant difference with PDLSCs-WT (P < .05, Figure 6B ).
| DISCUSSION
Recently, dental stem cell-induced tissue regeneration attracts much attention, and dental stem cells have been employed to successfully regenerate certain tissues in vitro or in large animal models. 13 PDLSCs are one kind of the dental stem cells and can be harvested easily from oral cavity and also can be obtained from discarded biological samples in dental clinics. 14 
Moshaverinia et al have reported that PDLSCs
showed superior chondrogenic differentiation potential than human bone marrow mesenchymal stem cells (hBMMSCs) in vitro and in vivo. 15 Our study also verified PDLSCs have chondrogenic differentiation potential, suggesting this population of dental stem cells could be a promising candidate for cartilage regeneration. KDM6A has been functionally linked to stem cell differentiation including osteogenic differentiation, cardiac differentiation, M2 macrophage differentiation, muscle differentiation and neuronal stem cell differentiation, etc. 1719 However, the effect of KDM6A on stem cell chondrogenic differentiation still remains unclear. Therefore, we sought to investigate if KDM6A has an impact on MSCs chondrogenesis in vitro.
In this study, shRNA was performed to deplete KDM6A and chemical inhibitor of EZH2 was employed to reverse the effect of KDM6A proteins are able to covalently modify histones, and these proteins are frequently found in complexes which are able to perform more than one type of modification reaction. KDM6A is a member of trx proteins family and is contained in trx-like group complex in drosophila.
Agger et al reported that a histone demethylase for H3K27 in a complex with a H3K4 methyltransferase can lead to the activation of a target gene. 20 And it is reported that KDM6A could function as the histone demethylase for H3K27 in MLL3/4 complex which may employ 2 distinct histone-modifying activities to synergistically activate target gene expression. 21 Previous studies showed that during cellular differentiation in NT2/D1, the occupancy of UTX at HOX gene promoters was increased, paralleled with a decrease in trimethyl H3K27
and an increase in trimethylation of H3K4, leading to the activation of transcription. 22 Li et al reported that knockdown of KDM6A decreased H3K4me2 and MLL4 (KMT2D) enrichments, 23 and Kim had demonstrated that knockdown of KDM6A resulted in decreased recruitment of MLL4 and decreased H3K4me3 levels on the promoters of MMP-9 et al. 24 Our study showed that knockdown of KDM6A led by Arifuzzaman. In Arifuzzaman's study, EPZ-6438 had no effect on Runx2 is identified as the key transcription factor regulating osteogenesis and chondrogenesis. [47] [48] [49] These 2 miRNAs act as endogenous negative regulators, which inhibit the expression of Runx2 protein to restrain BMSCs from differentiating into osteoblasts. 50 In this study, we investigated the expression of miR-204 and miR-211 to prove the involvement of miR-204 and miR-211 in PDLSCs during chondrogenic differentiation. During 3 weeks of chondrogenic differentiation, SOX9 kept increasing, while the transcription of Runx2 was increased at 3 days and subsequently decreased gradually. Relatively, miR-29a was significantly decreased after chondrogenic culture, the miR-204
and miR-211 decreased at 1 week after chondrogenic differentiation culture, and increased at 2 and 3 weeks. These results were consistent with Huang's report. Our results also showed that miR-204 and miR-211 were decreased after knockdown of KDM6A; however, EPZ-6438 could rescue the decrease.
Together, KDM6A was required in chondrogenic differentiation of
PDLSCs by demethylation of H3K27me3, and EZH2 inhibitor could rescue chondrogenesis of PDLSCs after knockdown of KDM6A, which suggests that upregulation of KDM6A or utilize of EZH2 inhibitor might improve MSC-mediated cartilage regeneration in chondrocytic deficient diseases such as OA. Future study should focus on the define mechanism by which KDM6A and its protein complexes regulate SOX9 transcription, thus promote chondrogenic differentiation of MSCs.
